By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ariadne said today it is collaborating with European consortium BIO-NMD on a project to identify biomarkers for Duchenne and Becker muscular dystrophies and collagen VI myopathies.

Ariadne will provide bioinformatics tools for identifying functional pathways, potential targets, and data outflow integration, the company said in a statement. Its software suit, Pathway Studio, will be the core product used for integrating data and information flow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.